NRD
AMGN icon

Nebula Research & Development’s Amgen AMGN Stock Holding History

Nebula Research & Development’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,531
Closed -$1.18M – 938
2024
Q4 		$1.18M Buy
+4,531
New +$1.34M 0.14% 242

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Nebula Research & Development's AMGN Position: Q1 2025 in Review

Nebula Research & Development sold out of Amgen (AMGN) in Q1 2025, closing a stake of 4,531 shares — an estimated $1.18M sold.

Nebula Research & Development first reported a position in AMGN in Q4 2024 and held it in 1 quarter. The position peaked at $1.18M in Q4 2024. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Nebula Research & Development reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Nebula Research & Development sold 4,531 Amgen shares in Q1 2025, an estimated $1.18M.
  • Nebula Research & Development first reported a position in Amgen in Q4 2024 and held it in 1 quarter.
  • Nebula Research & Development's Amgen position peaked at $1.18M in Q4 2024.
  • 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Nebula Research & Development's 13F filing for Q1 2025, filed 15 May 2025.